Self-tracking

Slow COMT, supplements, and feeling overstimulated.

A genetic shorthand can suggest a question to watch. It cannot tell you, in advance, exactly how caffeine or a supplement will feel for you.

Published July 20, 2026 · 8 min read

“Slow COMT” shows up often in conversations about feeling wired after a methylated B vitamin, getting jittery from coffee, or reacting more strongly than a friend to a new supplement. It offers a tidy explanation for an untidy experience. The reality is useful, but less certain: COMT is one enzyme in a complicated system, and a gene result cannot predict a feeling with the precision social media sometimes promises.

If a change leaves you restless, anxious, unusually alert, or sleeping poorly, that experience deserves attention. The most helpful next step is usually not to build a complete biochemical story from a single result. It is to safely reduce the guesswork: notice the timing, track the signal, avoid changing several things at once, and involve a qualified clinician when symptoms are significant or persistent.

What COMT does, in plain language

COMT is short for catechol-O-methyltransferase. It is an enzyme involved in processing compounds called catecholamines, including dopamine, norepinephrine, and epinephrine, as well as other catechol-containing substances. You may see this described as “clearing” neurotransmitters. That is a useful shortcut, though it leaves out a great deal of biology.

Like many genes, COMT has common variants. The one most often discussed is called Val158Met. Some research associates one version with lower COMT enzyme activity in certain settings, which is where the informal term “slow COMT” comes from. It is not a medical diagnosis, and it does not mean a person’s nervous system is permanently overstimulated.

Enzymes work in networks, not in isolation. The effect of a variant can differ across tissues and circumstances. Sleep, stress, hormone changes, medications, food, caffeine habits, and many other genes all matter. A consumer genetic report usually captures only a small slice of that context.

Why the overstimulation story is so compelling

The pattern is easy to recognize. Someone starts a new supplement, feels unusually awake or tense, then finds an explanation that mentions methyl donors and catecholamines. The timeline feels persuasive because it is real data: something changed, then they felt different.

The missing question is whether the change repeats, and whether anything else changed at the same time. A rough work week, a few short nights, an extra coffee, a new pre-workout, an illness, or anticipation about the supplement can all produce a similar feeling. Human attention is excellent at connecting nearby events, even when the connection is incomplete.

Some people report wired or anxious reactions after methylfolate, methyl-B12, or other products described as methyl donors. Those reports are not imaginary, but their mechanism and frequency are not always clear. Evidence is mixed for many online claims that a COMT variant predicts such a response. A report can be a good reason to pay attention, not a reason to assume a cause.

Caffeine sensitivity is a useful example

Caffeine is another place where the COMT story gets simplified. Some people can drink coffee late in the day and sleep normally; others feel shaky after a small amount. Genetics may influence caffeine response, but COMT is not the whole explanation, and caffeine is metabolized primarily by CYP1A2. The amount and timing consumed, tolerance, anxiety, sleep debt, and medication interactions can all matter.

That makes caffeine a good reminder of the difference between a plausible mechanism and a reliable personal prediction. A genetic label cannot tell you whether a 2 p.m. coffee caused tonight’s poor sleep. Your own repeated observations — especially when the pattern holds on otherwise similar days — can get closer to an answer.

How to run a simple personal observation

This kind of before-and-after tracking is not a formal randomized n-of-1 clinical trial. It is a structured way to learn from one person: you. It is not a substitute for medical care, and it cannot establish what will happen for everyone else. It can make your own decision less dependent on one memorable day.

Start with a clear question

Instead of “Does this make me weird?” choose a question you can observe: “Do I fall asleep later?” “Is my morning energy different?” “Do I feel more tense in the afternoon?” Pick an outcome you can record the same way each day. A 1–5 sleep-quality rating, bedtime, a simple anxiety or energy scale, and resting heart rate are examples of trackable signals; choose what is appropriate to your situation.

Establish your ordinary range

Before a planned change, collect about two weeks of baseline data when possible. Notice the difference between a typical day and a difficult one. That range matters because it keeps you from treating normal variation as a response. If your energy score already moves widely from day to day, a small shift after a change may not say much.

Make one change, and write down the real start date

Do not add a supplement, stop caffeine, and change your sleep schedule all at once if you hope to learn from the result. Keep the rest of your routine reasonably steady and record the day you actually began. If a change needs to be made for safety or on a clinician’s advice, follow that guidance rather than preserving an experiment.

Capture the context around unusual days

A short note is often enough: late coffee, travel, poor sleep the night before, a major deadline, alcohol, illness, or a missed meal. You are not trying to account for every molecule. You are looking for large alternative explanations before assigning all the credit or blame to one capsule.

Compare patterns, not isolated moments

After enough days, compare the before and after rather than replaying the most intense experience. Did sleep, mood, or energy move consistently? Was the change large compared with your usual variation? Did it coincide with something else? An honest answer may be “not enough data,” “no clear change,” or “worth discussing further,” and all three are more useful than certainty built from one night.

For a broader walkthrough of this kind of comparison, read Does That Supplement Actually Work?. It explains why a baseline and a marked start date matter even when the change feels obvious.

When not to treat it as a self-experiment

Self-tracking is for low-risk observation and better questions, not for pushing through alarming symptoms. If you experience severe anxiety, chest pain, fainting, a significant mood change, symptoms that feel urgent, or concerns involving a medication, seek appropriate medical guidance. A healthcare professional can help assess possible causes and interactions in a way an app or genetic report cannot.

The same applies to supplements that a clinician has recommended for a diagnosed condition: do not stop, start, or change a treatment plan based only on an app trend or an online article. Your data can support a conversation, but it should not replace it.

---

Why Traceline tracks the signal around the change

Traceline is for the ordinary question beneath the genetic shorthand: did something in my daily pattern change after I made one clear change? It supports a structured trial with a baseline, an actual exposure date, and a comparison after there are enough usable days. It can combine the information you choose to log with permitted Apple Health data, so a vague memory does not have to carry the whole conclusion.

Traceline does not diagnose COMT-related conditions, explain a symptom with a genotype, or recommend a supplement. It gives you a clearer record and makes room for the honest answer when a pattern is too weak to call. If your question started with a different genetic result, our guide to MTHFR: what it means and what to track uses the same practical approach.

Sources and further reading

• NCBI Gene: COMT catechol-O-methyltransferase
• Chen et al.: functional effects of COMT genetic variation
• Systematic review: genetic susceptibility to caffeine intake and metabolism
• BMJ: CONSORT extension for formal n-of-1 trials